Oxford Covid Vaccine
-
{
- All
- News
- Videos
-
Pfizer, Oxford Covid Vaccines "Highly Effective" In Elderly: UK Study
The Pfizer and Oxford-AstraZeneca vaccines have been "highly effective" in reducing coronavirus infections and severe illness among elderly people in Britain, with a more than 80 percent reduction in hospitalisation, official data showed Monday.
-
Oxford Kept UK Vaccine Volunteers In Dark On Dose Error: Report
About 1,500 of the initial volunteers in a late-stage clinical trial of the Oxford/AstraZeneca COVID-19 vaccine were given the wrong dose, but weren't informed that a mistake had been made after the blunder was discovered, documents obtained by Reuters show.
-
Covid Vaccine Has Good Immune Response With Two-Dose Regime, Says Oxford
Oxford's COVID-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a full-dose followed by a half-dose booster, the university said on Thursday.
-
PM Modi To Visit Serum Institute That's Making Oxford Vaccine, On Saturday
Prime Minister Narendra Modi will on Saturday visit the Pune-based Serum Institute of India, which has partnered with global pharma giant AstraZeneca and the Oxford University for COVID-19 vaccine, a senior official said today.
-
UK Hospital Told To Prepare For Oxford COVID Vaccine In November: Report
Staff at a major London hospital trust have been told to be ready to receive the first batches of the vaccine being developed by the University of Oxford and AstraZeneca Plc, The Sun newspaper reported on Monday.
-
Oxford Vaccine Trials Resume In UK, Were Paused Over Volunteer's Illness
Pharma giant AstraZeneca on Saturday said it had resumed a Covid-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill.
-
Oxford Covid Vaccine: Serum Institute Gets Nod For Phase 2, 3 Human Trial
The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of a COVID-19 vaccine candidate, developed by the University of Oxford, in the country.
-
Panel Recommends Oxford COVID Vaccine Partner For Phase 2,3 Human Trial
A subject expert committee on COVID-19 on Friday recommended to the country's drug regulator that permission be granted to Serum Institute of India (SII) for conducting the second and third phases of human clinical trials of the Oxford vaccine candidate.
-
India Readies 5 Sites For Final Phase Of Human Trials Of Oxford COVID Vaccine
Five sites across the country are ready for the third and final phase of human trials of the Oxford-AstraZeneca COVID-19 vaccine, Secretary of Department of Biotechnology (DBT) Renu Swarup said on Monday.
-
Pfizer, Oxford Covid Vaccines "Highly Effective" In Elderly: UK Study
The Pfizer and Oxford-AstraZeneca vaccines have been "highly effective" in reducing coronavirus infections and severe illness among elderly people in Britain, with a more than 80 percent reduction in hospitalisation, official data showed Monday.
-
Oxford Kept UK Vaccine Volunteers In Dark On Dose Error: Report
About 1,500 of the initial volunteers in a late-stage clinical trial of the Oxford/AstraZeneca COVID-19 vaccine were given the wrong dose, but weren't informed that a mistake had been made after the blunder was discovered, documents obtained by Reuters show.
-
Covid Vaccine Has Good Immune Response With Two-Dose Regime, Says Oxford
Oxford's COVID-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a full-dose followed by a half-dose booster, the university said on Thursday.
-
PM Modi To Visit Serum Institute That's Making Oxford Vaccine, On Saturday
Prime Minister Narendra Modi will on Saturday visit the Pune-based Serum Institute of India, which has partnered with global pharma giant AstraZeneca and the Oxford University for COVID-19 vaccine, a senior official said today.
-
UK Hospital Told To Prepare For Oxford COVID Vaccine In November: Report
Staff at a major London hospital trust have been told to be ready to receive the first batches of the vaccine being developed by the University of Oxford and AstraZeneca Plc, The Sun newspaper reported on Monday.
-
Oxford Vaccine Trials Resume In UK, Were Paused Over Volunteer's Illness
Pharma giant AstraZeneca on Saturday said it had resumed a Covid-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill.
-
Oxford Covid Vaccine: Serum Institute Gets Nod For Phase 2, 3 Human Trial
The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of a COVID-19 vaccine candidate, developed by the University of Oxford, in the country.
-
Panel Recommends Oxford COVID Vaccine Partner For Phase 2,3 Human Trial
A subject expert committee on COVID-19 on Friday recommended to the country's drug regulator that permission be granted to Serum Institute of India (SII) for conducting the second and third phases of human clinical trials of the Oxford vaccine candidate.
-
India Readies 5 Sites For Final Phase Of Human Trials Of Oxford COVID Vaccine
Five sites across the country are ready for the third and final phase of human trials of the Oxford-AstraZeneca COVID-19 vaccine, Secretary of Department of Biotechnology (DBT) Renu Swarup said on Monday.
